Sign in
4

Changes in Ownership

CORCEPT THERAPEUTICS INC Filed Acc 0001193125-25-267545

Chief Executive Officer sold 40,000 shares at an average $74.58 ($2,983,119)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

BELANOFF JOSEPH K · Chief Executive Officer

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2025-11-03 Sale : show line 1 in the form 10b5-1 −11,218 $74.08 $831,014 2,770,152 I
2025-11-05 Sale : show line 2 in the form 10b5-1 −14,355 $74.20 $1,065,084 2,755,797 I
2025-11-05 Sale : show line 3 in the form 10b5-1 −10,837 $75.14 $814,262 2,744,960 I
2025-11-05 Sale : show line 4 in the form 10b5-1 −3,590 $75.98 $272,760 2,741,370 I
Open-market sales · 40,000 sh · avg $74.58 · $2,983,119
Loading xslF345X05/ownership.xml…